AstraZeneca
AZN
AZN
449 hedge funds and large institutions have $8.63B invested in AstraZeneca in 2016 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 113 increasing their positions, 161 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
20% less capital invested
Capital invested by funds: $10.8B → $8.63B (-$2.19B)
30% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 161
Holders
449
Holding in Top 10
6
Calls
$211M
Puts
$76.1M
Top Buyers
| 1 | +$252M | |
| 2 | +$237M | |
| 3 | +$203M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$40.4M |
| 5 |
Jennison Associates
New York
|
+$39.3M |
Top Sellers
| 1 | -$434M | |
| 2 | -$148M | |
| 3 | -$126M | |
| 4 |
Renaissance Technologies
New York
|
-$118M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$92.5M |